Shionogi Eyes PIII Topline Readout for COVID Pill in Aug-Sept., Sticks to H1 Approval Plan

August 2, 2022
Even after its COVID-19 pill stumbled on Japan’s newly created emergency approval pathway, Shionogi says it will not give up on its plan to obtain the regulatory nod by the end of September, noting that the company is prepping to...read more